Amino acids in the BPC-157 sequence, GEPPPGKPADDAGLV. An identity fact, not a product claim.
Form Labs catalog record for BPC-15715-amino-acid research peptide
BPC-157
A synthetic peptide studied in laboratory and animal models of tissue and gut repair. Supplied for laboratory research only.
Your stomach runs on acid strong enough to break down a meal, and somehow does not digest itself. BPC-157 comes out of the research into why. Supplied freeze-dried, for laboratory research only.
Current lot pricing
$99.00 AUD
Base vial price: $99.00 AUD
Vial size10 mg
Ships from Perth, Australia PostFree standard shipping over $250Plain, discreet packagingStore at 2-8 C
Supplied strictly as reference material for in-vitro laboratory research. Not a medicine, supplement, or food. Not for human or veterinary use.
Research use onlyWhy this molecule is studied
Why researchers study it.
Start with the honest bit, because it frames everything below. Almost all of the evidence here is cell cultures and rats. The first properly controlled human trial only began recruiting in 2026, and results are not expected until around 2027. BPC-157 is not an approved medicine anywhere.
With that said, here is where it came from. The stomach is a genuinely hostile place to be a piece of tissue, and in the early 1990s researchers looking into how the lining survives it described a protective substance in gastric juice. BPC-157 - the name is short for Body Protection Compound - is the stable synthetic peptide modelled on part of that sequence.
The obvious question, and the one the research has chased ever since, is whether that protective signalling only works in the stomach or does something similar elsewhere. So the studies went looking: gut lining first, then tendon and ligament, then blood vessels.
This page is about that research and about the batch you are getting. It is not a claim about what this vial will do, and it is not for people or animals to take.
The research
What the published studies found.
When the protective gastric-juice substance behind BPC-157 was first described. The evidence since then is almost all lab and animal (rodent) work.
Sikiric et al., J Physiol Paris, 1993When the first randomised, controlled human trial began recruiting. Its results aren't in yet - expected around 2027. BPC-157 is not an approved medicine.
ClinicalTrials.gov - NCT07437547Figures outside lot paperwork describe third-party research records for the molecule. They are not Form Labs product results or use claims.
Read the full research guideIdentity, papers, and research-use boundariesMechanism notes
Plain-language research labels.
It helps to think about what repairing a piece of tissue actually needs: something to limit the damage, something to knit it back together, and a supply line of blood to feed the work. Those three are exactly where the research went looking. Here is what each area was actually measuring - in dishes and in rodents, not in people.
Gut & stomach lining
Where it all started. The early rodent work looked at how the stomach and gut lining hold up under stress, and how quickly they knit back together afterwards. That is where the 'body protection' name came from, and it is still the best-covered corner of the literature.
Tendon, ligament & muscle
The obvious next question: if a protective signal helps a lining repair itself, does it do anything for the tissue that holds you together? Later rat and cell studies looked at tendon, ligament and muscle, and whether they knit back together faster in those models.
Blood-vessel growth
The one that ties the other two together. Repair needs blood supply - new vessels growing into the damaged area, which researchers call angiogenesis. Several studies looked at whether BPC-157 prompts that, and at a signalling receptor called VEGFR2 that sits in the middle of it.
Order anchor
Form Laboratories
BPC-157 with live bundle pricing.
- Independently tested for purity and identity, with the result printed on the lab report
- A batch number on every vial that matches its lab report, so you can always check the two line up
- Ships from Perth via Australia Post in plain, unbranded packaging, with tracking emailed
- 30-day purity guarantee: if an independent re-test comes back below the purity on the report, we refund the order in full
Base tier
$99.00 AUD
Single vial / 10 mg / $99.00 AUD per vial
Ships after order review. Reference material for research use only.
Testing documentation
Lot-level records
Australia-wide dispatch
Plain, tracked delivery
Plain fulfilment
Discreet outer packaging
Research use only
No human-use claims
COA proof
Batch paperwork before checkout.
98.6%
Measured purity is matched to the product record and batch paperwork.
Purity test (HPLC) at or above 98%Identity confirmedScreened for bacterial residue (endotoxin)
Certificate of AnalysisBPC-2506
CompoundBPC-157
LotBPC-2506
Purity98.6%
Net peptide10 mg
AppearanceFreeze-dried reference material
ReleasedCurrent product record
Download COA summary
Build your stack
Study alongside other catalogue references.
These products are shown as catalogue pairings only. Add any line to the same cart for order review.
Thymosin beta-4 fragment peptide
TB-500
$109 AUD
Researchers can study this catalogue reference alongside BPC-157 in the same order record.
Two-peptide research set
BPC-157 & TB-500
$119 AUD
Researchers can study this catalogue reference alongside BPC-157 in the same order record.
Naturally occurring copper peptide
GHK-Cu
$79 AUD
Researchers can study this catalogue reference alongside BPC-157 in the same order record.
FAQ
Questions, answered plainly.
BPC-157 is supplied as laboratory research material only. It is 21+ only, not for human consumption, and not for veterinary use.
Yes. The product page lists lot, identity, purity, appearance, release status, and storage notes for BPC-157.
Follow the label and matching COA paperwork. This page repeats 2-8 C storage guidance and light-protection notes before checkout.
BPC-157 - short for 'Body Protection Compound-157' - is a synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV), based on a partial sequence of a protective protein found in gastric juice. It is studied, almost entirely in cell and animal models, for how tissues such as the gut, tendons, and blood vessels repair. The spec sheet lists it with formula C62H98N16O22 and a molecular weight of 1419.54 g/mol. It is not an approved medicine, and Form Labs supplies it freeze-dried for laboratory research only.
Barely. There are no completed, published human trials, and a first randomised controlled trial only began in 2026. The research to date is almost entirely in cell cultures and rodents. That is why the page treats the published work as study context rather than as evidence about any Form Labs product.
The current batch is lot BPC-2506, supplied as a 10 mg freeze-dried vial at 98.6% purity. The spec sheet and COA both list storage at 2-8 C, dry and protected from light. Identity, appearance, purity, and release status for lot BPC-2506 stay tied to the matching lab report. These are batch and handling details, not preparation or use instructions.
In published research, BPC-157 is studied for its possible role in how tissues repair - the gut and stomach lining, tendons and ligaments, and the growth of new blood vessels (angiogenesis). Almost all of that work has been done in cell cultures and rodents. These are research questions, not effects the product is claimed to have in people.
BPC-157 research is almost entirely preclinical. Rodent studies - for example Chang and colleagues (Journal of Applied Physiology, 2011) on tendon healing, and Hsieh and colleagues (Journal of Molecular Medicine, 2017) on blood-vessel growth - reported effects in those animal models. A 2022 study by He and colleagues measured how rats and dogs cleared it. What these animal findings mean for humans is not established.
Barely. There are no completed, published randomised controlled trials of BPC-157 in humans - only a few very small, uncontrolled pilot reports. The first properly controlled human trial (a hamstring-injury study, ClinicalTrials.gov NCT07437547) began recruiting in 2026, with results expected around 2027. Until then, the human evidence for BPC-157 is very limited.
BPC-157 and TB-500 are unrelated compounds that both appear in tissue-repair research. BPC-157 is a 15-amino-acid peptide (GEPPPGKPADDAGLV) based on a protein in gastric juice, studied mostly in gut, tendon and blood-vessel models. TB-500 is a 7-amino-acid fragment (Ac-LKKTETQ) of the protein thymosin beta-4, studied mostly for cell movement and repair. Both are preclinical, and there's no research on combining them.
BPC-157 is not an approved medicine in Australia - it is not on the Australian Register of Therapeutic Goods, and the TGA has not evaluated it for safety, quality or effectiveness. Form Labs supplies BPC-157 strictly as a laboratory research material, not for human or veterinary use. In sport, BPC-157 is on the World Anti-Doping Agency prohibited list.
No. BPC-157 has not been approved as a medicine by any regulator - not the TGA in Australia, the FDA in the United States, or the EMA in Europe - for any use. BPC-157 remains an investigational research compound, and Form Labs sells it only as reference material for laboratory research.
BPC-157 is a pentadecapeptide - 15 amino acids - with the sequence GEPPPGKPADDAGLV. Its molecular formula is C62H98N16O22 and its molecular weight is about 1419.5 g/mol. The free-peptide CAS number is 137525-51-0. Each batch's exact identity and purity are confirmed on its independent lab report.
The name 'Body Protection Compound' comes from the original 1990s research by a University of Zagreb group, who described a protective substance in gastric juice. BPC-157 is the stable synthetic peptide later modelled on part of that sequence. On this page the name is a research label from that history - not a claim that BPC-157 protects the body.
This batch of BPC-157 is listed at 98.6% purity. Every batch is tested by an independent laboratory: a purity test (HPLC) measures how much of the powder is the intended compound, an identity test confirms it's the right one, and it's screened for bacterial residue (endotoxin). The result is printed on the lab report tied to your vial's batch number.
The research-peptide market is largely unregulated, and independent analyses have repeatedly found products that are under-strength, mislabelled or contaminated. That's why every Form Labs batch of BPC-157 ships with an independent lab report confirming its purity and identity, and why we back it with a 30-day purity guarantee. It's also why BPC-157 should be handled only as a research material.
BPC-157 ships from Perth via Australia Post in plain, unbranded packaging once your payment clears, with tracking emailed. On arrival, store the freeze-dried vial in the fridge at 2-8 C and keep it out of light. Delivery is Australia-only; a flat rate applies, with free standard shipping on orders over $250.
Add the size and quantity of BPC-157 you want to your cart and check out. Instead of paying by card, you'll receive an emailed invoice with our bank details - pay by bank transfer, quoting the reference. Once the payment clears we pack and send your order, and email you tracking. A faster transfer (PayID or Osko) gets things moving sooner.
Every Form Labs compound, BPC-157 included, carries a 30-day purity guarantee. If an independent lab re-tests the batch within 30 days and it comes back below the purity stated on its lab report, we refund the order in full - and you don't need to send the vial back.
No. BPC-157 from Form Labs is supplied strictly as reference material for laboratory research - not a medicine, supplement or food, and not for people or animals to take, and 21+ only. The research described on this page concerns the BPC-157 molecule in published studies, not a Form Labs product.
Form your biology
BPC-157, with the batch details visible.
Before you order, check the batch number shown on the page against the lab report for that batch.
Added to cart